Put Options

10 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.64 - $210.12 $49,091 - $63,036
300 Added 23.08%
1,600 $310,000
Q2 2024

Aug 14, 2024

SELL
$172.27 - $223.95 $172,270 - $223,950
-1,000 Reduced 43.48%
1,300 $233,000
Q1 2024

May 15, 2024

SELL
$220.09 - $273.15 $176,072 - $218,519
-800 Reduced 25.81%
2,300 $513,000
Q4 2023

Feb 14, 2024

SELL
$181.44 - $260.22 $489,888 - $702,594
-2,700 Reduced 46.55%
3,100 $779,000
Q3 2023

Nov 14, 2023

BUY
$240.69 - $338.77 $457,311 - $643,663
1,900 Added 48.72%
5,800 $1.4 Million
Q2 2023

Aug 14, 2023

SELL
$271.54 - $344.06 $81,462 - $103,218
-300 Reduced 7.14%
3,900 $1.34 Million
Q1 2023

May 15, 2023

SELL
$220.43 - $278.69 $484,946 - $613,118
-2,200 Reduced 34.38%
4,200 $1.17 Million
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $972,032 - $1.46 Million
6,400 New
6,400 $1.42 Million
Q2 2022

Aug 08, 2022

BUY
$116.09 - $227.33 $208,962 - $409,194
1,800 Added 58.06%
4,900 $610,000
Q3 2021

Nov 15, 2021

BUY
$250.72 - $291.24 $777,232 - $902,844
3,100 New
3,100 $826,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.